Literature DB >> 804023

Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.

V L Sutter, S M Finegold.   

Abstract

The agar dilution technique was used for determination of the bacteriostatic activity of carbenicillin, penicillin G, cefazolin, cephaloridine, cefoxitin, and cephalothin agaomst a variety of anaerobic bacteria. Carbenicillin showed a high level of activity at a concentration of smaller than or equal to 100 mug/ml; only five of 123 strains of Bacteroides fragilis, one strain of Bifidobacterium eriksonii, and one strain of Clostridium bifermentans were resistant to a concentration of larger than or equal to 100 mug/ml. Cefoxitin, a beta-lactamase-resistant drug, was highly active against B. fragilis and most other anaerobes at a concentration of smaller than or equal to 32 mug/ml; the exceptions were one strain of Bacteroides species and 13 of 28 strains of Clostridium species. The other cephalosporins were less active against B. fragilis but exhibited good activity against most of the other strains tested. Bactericidal concentrations of cefoxitin and cephalothin were determined for 51 selected strains by the broth dilution technique, and the activities of these drugs were compared with those of two other drugs (clindamycin and metronidazole) known to be very active against anaerobes. Metronidazole wasthe most consistently bactericidal of the four drugs tested for this activity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 804023     DOI: 10.1093/infdis/131.4.417

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.

Authors:  B Olsson; K Dornbusch; C E Nord
Journal:  Med Microbiol Immunol       Date:  1977-10-07       Impact factor: 3.402

2.  Susceptibility testing of anaerobic bacteria with 100-microg carbenicillin disks.

Authors:  W W Laslie; D W Lambe
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

3.  Susceptibility of anaerobic bacteria to cofoxitin and related compounds.

Authors:  V T Bach; I Roy; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

4.  Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

Authors:  E C Ernst; S Berger; M Barza; N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

5.  Carbenicillin in the treatment of infections involving anaerobic bacteria.

Authors:  R M Swenson; B Lorber
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

6.  Susceptibilities of Bacteroides and Fusobacterium spp. from foot rot in goats to 10 beta-lactam antibiotics.

Authors:  S Piriz Duran; J Valle Manzano; R Cuenca Valera; S Vadillo Machota
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

7.  Comparison of kill-kinetic studies with agar and broth microdilution methods for determination of antimicrobial activity of selected agents against members of the Bacteroides fragilis group.

Authors:  C W Stratton; L S Weeks; K E Aldridge
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

8.  Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.

Authors:  H Wexler; W T Carter; B Harris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria.

Authors:  M Gurwith; W Albritton; B Lank; G Harding; A Ronald
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

10.  [In vitro activity of mezlocillin, azlocillin and carbenicillin against bacteroidaceae with particular reference to bacteroides fragilis (author's transl)].

Authors:  H Werner; C Krassemann; J Ungerechts; H J Schmitz
Journal:  Infection       Date:  1977       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.